TY - JOUR
T1 - Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana
T2 - a pilot study
AU - Effah, Kofi
AU - Tekpor, Ethel
AU - Wormenor, Comfort Mawusi
AU - Allotey, John
AU - Owusu–Agyeman, Yaa
AU - Kemawor, Seyram
AU - Agyiri, Dominic
AU - Amenu, Johnpaul
AU - Gmanyami, Jonathan M.
AU - Adjuik, Martin
AU - Duedu, Kwabena Obeng
AU - Der, Joyce B.
AU - Essel, Nana Owusu Mensah
AU - Kweku, Margaret
PY - 2024/11/8
Y1 - 2024/11/8
N2 - The World Health Organization has set ambitious goals to eliminate cervical cancer, necessitating evidence on increasing coverage and access to screening and treatment in high-burden areas. We implemented a pilot program to assess the feasibility of obtaining self-collected specimens for high-risk human papillomavirus (hr-HPV) testing in Nzulezo stilt village, a hard-to-reach community in Ghana, and inviting only hr-HPV-positive women to a central location for colposcopy and possible treatment. Subsequently, this study aimed to investigate the prevalence of hr-HPV infection and cervical lesions among the women and to explore factors potentially associated with hr-HPV infection among them.
AB - The World Health Organization has set ambitious goals to eliminate cervical cancer, necessitating evidence on increasing coverage and access to screening and treatment in high-burden areas. We implemented a pilot program to assess the feasibility of obtaining self-collected specimens for high-risk human papillomavirus (hr-HPV) testing in Nzulezo stilt village, a hard-to-reach community in Ghana, and inviting only hr-HPV-positive women to a central location for colposcopy and possible treatment. Subsequently, this study aimed to investigate the prevalence of hr-HPV infection and cervical lesions among the women and to explore factors potentially associated with hr-HPV infection among them.
UR - https://www.open-access.bcu.ac.uk/15961/
U2 - 10.1186/s12885-024-13113-9
DO - 10.1186/s12885-024-13113-9
M3 - Article
SN - 1471-2407
VL - 24
JO - BMC Cancer
JF - BMC Cancer
IS - 1
ER -